rosuvastatin/ezetimibe combination
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for rosuvastatin/ezetimibe combination, covering 2020-12-14 to 2020-12-14. Get the full timeline:
Most recent: Clinical Trial Update: High-intensity Rosuvastatin vs. Moderate-intensity Rosuvastatin/Ezetimibe in High Atherosclerotic Cardiovascular Disease Risk Patients With Type 2 Diabetes [Phase 4]